Search Contact us Menu
  • Types of Cover

    Individuals & Families

    Where We Cover

    Resources

    For Members

  • Employers

    Employers

    For Members

  • Our Plans

    IGO/NGO & Government

    For Members

  • Health Blog

    Topics

  • Individuals & Families

  • Employers

  • IGO/NGO & Government

  • Health Blog

  • For Providers
  • For Brokers

  • HomeHealth BlogThought Leadership

    Protecting Workforce Vitality Through MSK Prevention

    Protecting Workforce Vitality Through MSK Prevention

    Published on 08 Jan 2026

    Musculoskeletal (MSK) conditions are a leading cause of declining vitality worldwide. Discover how early MSK prevention can protect workforce resilience, the latest global insights, and how Cigna Healthcare supports proactive, sustainable approaches to employee health.

    Musculoskeletal (MSK) issues are rising sharply worldwide and have become a major vitality challenge. Chronic MSK pain affects far more than physical movement: it drains energy, disrupts mental well-being, limits daily functioning and ultimately weakens workforce resilience and productivity. For employers, the message is clear: preventing MSK before it becomes chronic is one of the most effective long-term strategies for protecting employee vitality and sustaining a high-performing workforce.

    MSK as a global and growing vitality challenge

    Musculoskeletal (MSK) conditions affect the muscles, joints and connective tissues that support movement. They can be acute, appearing suddenly and severely, or develop gradually into long-lasting, chronic pain. In the workplace, common contributors include repetitive motions such as typing, poor ergonomics and prolonged sitting. As MSK issues progress, everyday activities like walking, standing or sitting for extended periods can become uncomfortable, making it harder for people to move freely and maintain energy throughout the day.

    MSK conditions are often dismissed as routine aches and pains, yet they are now one of the world’s leading causes of lost health and reduced daily functioning. These conditions can limit mobility and energy long before people seek medical care, and long before employers see a corresponding rise in claims.

    Globally, more than 1.7 billion people live with MSK conditions, making them the largest contributor to disability worldwide [1]. Early signs are already visible in day-to-day life: our global Cigna Healthcare International Health 2025 study on well-being and vitality found that 37% of respondents said their physical health meant they accomplished less than they would like at home, a clear signal that physical limitations are quietly reducing everyday vitality [2].

    As MSK issues become chronic, their impact extends beyond discomfort, influencing how people think, feel, sleep and participate in daily life, both at home and at work.

    The hidden cost: when chronic MSK quietly reduces vitality and performance

    When MSK conditions persist, their impact shifts from isolated pain to a broader erosion of vitality. Chronic discomfort drains energy, disrupts sleep, limits mobility and reduces confidence, often long before a formal diagnosis is made.

    Many MSK issues begin subtly, with stiffness or restricted movement. Over time, chronic pain can create a self-reinforcing cycle: pain reduces movement, reduced movement intensifies pain, and together they lower overall vitality. Fatigue increases, stress rises and participation in daily and social life diminishes.

    In the workplace, this often shows up as presenteeism rather than absence. Employees may be physically present yet operating at reduced capacity, with less stamina, slower task execution and diminished ability to collaborate or problem-solve. For employers, the true cost of MSK emerges long before medical claims rise. Vitality — the combination of physical, mental, social and financial well-being — is slowly eroded in the background.

    Prevention matters: early awareness and everyday action to avoid chronic decline

    Preventing MSK issues before they escalate is far more effective than treating late-stage pain, and it protects long-term vitality in ways reactive care cannot. Early signs such as stiffness or limited mobility are often overlooked, yet they represent the most important window for intervention.

    Evidence shows that regular movement and mobility-focused exercise can substantially reduce musculoskeletal pain and its impact among sedentary workers. In a controlled workplace study, a structured exercise programme led to reductions in pain intensity and duration of up to 70%, alongside significant decreases in work absenteeism [3]. Simple habits, such as stretching, mobility work, posture resets and early reporting of discomfort, help maintain flexibility and interrupt the cycle that leads to chronic pain.

    Awareness also plays a critical role. Tools such as Flex-ray, Cigna Healthcare’s MSK risk-awareness and screening resource, help individuals identify areas of limited mobility and receive personalised guidance, encouraging early action through everyday movement. Flex-ray is not a clinical intervention or treatment, but an educational tool designed to help people understand and manage their MSK risk.

    For employers, supporting early awareness and preventive habits helps reduce chronicity before it begins to affect mental well-being, energy and performance. Small steps taken early can protect long-term vitality across global workforces.

    The global picture: a universal workforce challenge

    MSK affects workers across every region and demographic group, reflecting shared pressures such as sedentary lifestyles, increased stress and limited movement. Ageing populations, alongside occupational factors from prolonged desk-based work to roles involving repetitive strain or heavy lifting, further contribute to the growing global prevalence of MSK conditions.

    In Europe, MSK disorders are among the top causes of disability-adjusted life years, with back and neck pain highly prevalent across working-age adults [1]. Across Asia-Pacific, urbanisation and desk-based work are driving rising MSK incidence, prompting greater emphasis on early education and mobility programmes [4]. In the Middle East and Africa, shifts toward sedentary work are contributing to higher MSK burden in younger populations [4]. In the Americas, chronic pain affects around one in five adults, with MSK disorders among the leading causes of reduced workforce participation [5].

    Despite regional differences, the pattern is consistent. MSK is widespread, increasingly relevant to workforce health strategies worldwide.

    The employer opportunity: sustaining vitality through early support

    Employers often recognise MSK only when pain becomes chronic, yet the loss of vitality begins much earlier. To combat this, organisations should:

    1. Identify risk sooner through awareness tools and simple mobility check-ins.
    2. Encourage everyday movement by normalising micro-breaks, stretching and posture variation.
    3. Empower self-care with accessible guidance and practical daily mobility exercises.
    4. Support mental well-being by reducing the psychological strain associated with untreated, persistent pain.
    5. Provide the right tools so employees are supported with proper work set-ups to prevent strain.

    MSK prevention is not a wellness add-on. It’s a strategic investment in the conditions that enable employees to perform, adapt and thrive.

    Cigna Healthcare’s perspective: MSK prevention as a pathway to vitality

    Cigna Healthcare’s global insights consistently show that MSK pain and declining vitality are closely connected, reinforcing why prevention must be a core part of whole-person well-being, not just a physical health initiative.

    This is supported by our awareness-led prevention tools such as Flex-ray, global education that emphasises movement and mobility, and employer guidance to help integrate MSK prevention into broader vitality strategies.

    “Supporting MSK health is one of the most effective ways to strengthen vitality. When people stay mobile, they feel better, think better and are better able to thrive, long before pain becomes chronic.”

    Dr. Stella George, Chief Medical Officer, Cigna Healthcare International Health

    Protecting vitality starts before pain turns chronic

    MSK prevention offers employers a powerful opportunity to strengthen vitality before problems become chronic. By raising awareness, encouraging everyday movement and supporting early intervention, organisations can reduce long-term pain, protect mental well-being and build healthier, more resilient teams.

    For organisations ready to take the next step, Cigna Flex-ray can help individuals understand their MSK risk early and act proactively.

    Discover how Cigna Healthcare can help you integrate MSK prevention into a globally relevant well-being strategy that strengthens long-term vitality.

    Sources  

    [1] WHO - Musculoskeletal Conditions Fact Sheet (2023)

    [2] Cigna Healthcare International Health - Global Well-being & Vitality Study (2025)

    [3] Healthcare (MDPI) - Effects of a Comprehensive Workplace Exercise Program on Musculoskeletal Pain and Work Absence in Office Workers (2024)

    [4] Frontiers in Public Health - Global, regional, and national burden of musculoskeletal disorders and implications for working-age populations (2025)

    [5] Centers for Disease Control and Prevention (CDC) -  Chronic Pain and High-Impact Chronic Pain Among Adults, United States, 2019–2021 (2023)

    Related articles

    Thought Leadership

    Solving the issues of international compliance with Cigna Healthcare

    When HR managers oversee international employees, they may struggle with the challenges of maintaining compliance with global health regulations. It can be difficult to find the perfect balance between comprehensive coverage and cost efficiency, but the newest guide from Cigna Healthcare, Global Health Benefits is designed with professionals like yourself in mind.

    Thought Leadership

    The Biosimilars Opportunity: Expanding Access and Affordability

    As specialty-drug costs rise, biosimilars are giving employers new ways to make advanced treatments more affordable, improving access to care and helping employees stay healthier and more productive.


    ©Cigna 2026

    This article serves only as a reference and is intended for informational purposes only. Nothing in this article constitutes legal, tax, financial planning, health or medical advice including diagnosis or treatment. Any reference to products or services offered by Cigna are available except where prohibited by applicable law and subject to terms and conditions.

    © Cigna Healthcare. All rights reserved.

    *Please note, this is a representation of the benefits available and does not contain the terms, conditions, and exclusions specific to each benefit. The benefits may be subject to change. Some benefits may be part of an optional module. Please see the Customer Guide for full details.

    This website is provided by Cigna European Services (UK) Limited, a company incorporated in England and Wales having its registered address at 13th Floor, 5 Aldermanbury Square, London EC2V 7HR and registered number 00199739. The Cigna Healthcare name, logo and other Cigna Healthcare marks are owned by Cigna Intellectual Property, Inc., licensed for use by The Cigna Group and its operating subsidiaries.

    Our Policies are underwritten by Cigna Global Insurance Company Limited, a private limited company under Guernsey Law, with registered address office at PO Box 155, Mill Court, La Charroterie, St Peter Port, Guernsey, GY1 4ET, and company number 41925. Cigna Global Insurance Company Limited is authorised and regulated by the Guernsey Financial Services Commission for the conduct of insurance business in Guernsey.

    This communication is being issued and/or distributed by Cigna Insurance Management Services (DIFC) Limited which is regulated by the Dubai Financial Services Authority.